Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer

Purpose: To assess the recurrence and birth rates among patients with non-epithelial ovarian cancer. Methods: The study included 146 patients with germ cell (GCT, n = 84) and sex cord-stromal tumors (SCST, n = 62), who underwent fertility-sparing surgery. Adjuvant chemotherapy was administered to 86...

Full description

Bibliographic Details
Main Authors: Szymon Piątek, Iwona Szymusik, Piotr Sobiczewski, Wojciech Michalski, Magdalena Kowalska, Mariusz Ołtarzewski, Mariusz Bidziński
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/16/4170
_version_ 1797585174251175936
author Szymon Piątek
Iwona Szymusik
Piotr Sobiczewski
Wojciech Michalski
Magdalena Kowalska
Mariusz Ołtarzewski
Mariusz Bidziński
author_facet Szymon Piątek
Iwona Szymusik
Piotr Sobiczewski
Wojciech Michalski
Magdalena Kowalska
Mariusz Ołtarzewski
Mariusz Bidziński
author_sort Szymon Piątek
collection DOAJ
description Purpose: To assess the recurrence and birth rates among patients with non-epithelial ovarian cancer. Methods: The study included 146 patients with germ cell (GCT, n = 84) and sex cord-stromal tumors (SCST, n = 62), who underwent fertility-sparing surgery. Adjuvant chemotherapy was administered to 86 (58.9%) patients. Most cases (133 out of 146) were staged FIGO I. Results: The 5- and 10-year disease-free survival rates were 91% and 83%, respectively. The recurrence risk was not associated with tumor histology, stage or age. Twenty-four months after the treatment, the rate of recurrence was higher than the rate of childbearing. The childbearing rates kept rising after the treatment and exceeded the rate of recurrence after 2 years. The cumulative incidence rates of birth 36, 60 and 120 months after treatment were 13.24%, 20.75%, and 42.37%, respectively. Chemotherapy was not related to childbearing. The patients’ age was related to the chance of childbearing. Conclusions: The prognoses of GCT and SCST are similar. Close follow-ups along with contraception should be offered to women during the first two years after treatment due to the increased risk of recurrence. After this period, relapses are rare and women can safely become pregnant.
first_indexed 2024-03-11T00:03:14Z
format Article
id doaj.art-53c338d8513648f4a8cc9377d0d6346d
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T00:03:14Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-53c338d8513648f4a8cc9377d0d6346d2023-11-19T00:34:20ZengMDPI AGCancers2072-66942023-08-011516417010.3390/cancers15164170Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian CancerSzymon Piątek0Iwona Szymusik1Piotr Sobiczewski2Wojciech Michalski3Magdalena Kowalska4Mariusz Ołtarzewski5Mariusz Bidziński6Department of Gynecologic Oncology, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, PolandDepartment of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education, 80 Ceglowska Street, 00-001 Warsaw, PolandDepartment of Gynecologic Oncology, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, PolandDepartment of Gynecologic Oncology, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, PolandDepartment of Gynecologic Oncology, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, PolandInstitute of Mother and Child, 01-211 Warsaw, PolandDepartment of Gynecologic Oncology, The Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, PolandPurpose: To assess the recurrence and birth rates among patients with non-epithelial ovarian cancer. Methods: The study included 146 patients with germ cell (GCT, n = 84) and sex cord-stromal tumors (SCST, n = 62), who underwent fertility-sparing surgery. Adjuvant chemotherapy was administered to 86 (58.9%) patients. Most cases (133 out of 146) were staged FIGO I. Results: The 5- and 10-year disease-free survival rates were 91% and 83%, respectively. The recurrence risk was not associated with tumor histology, stage or age. Twenty-four months after the treatment, the rate of recurrence was higher than the rate of childbearing. The childbearing rates kept rising after the treatment and exceeded the rate of recurrence after 2 years. The cumulative incidence rates of birth 36, 60 and 120 months after treatment were 13.24%, 20.75%, and 42.37%, respectively. Chemotherapy was not related to childbearing. The patients’ age was related to the chance of childbearing. Conclusions: The prognoses of GCT and SCST are similar. Close follow-ups along with contraception should be offered to women during the first two years after treatment due to the increased risk of recurrence. After this period, relapses are rare and women can safely become pregnant.https://www.mdpi.com/2072-6694/15/16/4170non-epithelial ovarian cancergerm cell tumorsex cord-stromal tumorfertility-sparing surgeryobstetric outcomebirth rate
spellingShingle Szymon Piątek
Iwona Szymusik
Piotr Sobiczewski
Wojciech Michalski
Magdalena Kowalska
Mariusz Ołtarzewski
Mariusz Bidziński
Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer
Cancers
non-epithelial ovarian cancer
germ cell tumor
sex cord-stromal tumor
fertility-sparing surgery
obstetric outcome
birth rate
title Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer
title_full Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer
title_fullStr Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer
title_full_unstemmed Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer
title_short Obstetric Results after Fertility-Sparing Management of Non-Epithelial Ovarian Cancer
title_sort obstetric results after fertility sparing management of non epithelial ovarian cancer
topic non-epithelial ovarian cancer
germ cell tumor
sex cord-stromal tumor
fertility-sparing surgery
obstetric outcome
birth rate
url https://www.mdpi.com/2072-6694/15/16/4170
work_keys_str_mv AT szymonpiatek obstetricresultsafterfertilitysparingmanagementofnonepithelialovariancancer
AT iwonaszymusik obstetricresultsafterfertilitysparingmanagementofnonepithelialovariancancer
AT piotrsobiczewski obstetricresultsafterfertilitysparingmanagementofnonepithelialovariancancer
AT wojciechmichalski obstetricresultsafterfertilitysparingmanagementofnonepithelialovariancancer
AT magdalenakowalska obstetricresultsafterfertilitysparingmanagementofnonepithelialovariancancer
AT mariuszołtarzewski obstetricresultsafterfertilitysparingmanagementofnonepithelialovariancancer
AT mariuszbidzinski obstetricresultsafterfertilitysparingmanagementofnonepithelialovariancancer